5.40 USD
▲+0.23+6.51%
盘后 5.04 -0.66%
2026-08-03
市值
$53.62M
市盈率
—
EPS
-3.90
股息率
—
52 周区间
3.53 – 10.48
成交量
178.40K
Beta
1.10
目标价
33.55
52W 低 3.5352W 高 10.48
价格走势
公司简介
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in...